Indications & Usage
Directions: FOR TOPICAL USE ONLY.
Rosmarinus Lavendula Special Order
FDA Label NDC 48951-8233
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc. for the product Rosmarinus Lavendula Special Order (NDC 48951-8233). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage, dosage & administration, otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, warnings, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Apply to skin as needed. Under age 2: Consult a doctor.
Otc - Active Ingredient
Active Ingredients: Prunus spinosa e flor. et summ. 5X/10X/15X, Anus 6X/15X, Copper oxide 10X, Conchae 10X/15X, Lavandula 10X, Rosa cum ferro 10X, Rosmarinus e pl. tota 10X/15X, Stannum 10X, Urtica e pl. tota 10X/15X, Cutis 12X, Ovarium 15X, Placenta 15X
Inactive Ingredient
Inactive Ingredients: White petrolatum, Mineral oil, Lanolin, Silica gel, Copper oxide, Geranium oil, Rose oil
Otc - Purpose
Use: Temporary relief of anal itching.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Warnings
Warnings: FOR EXTERNAL USE ONLY. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions, if conditions worsen or persist, or accidental ingestion occurs. If pregnant or nursing, consult a doctor before use. Avoid contact with eyes. Do not use if safety seal is broken or missing.
Otc - Questions
Questions? Call 866.642.2858 Made with care by Uriel, East Troy, WI 53120 www.urielpharmacy.com
Package Label.Principal Display Panel
Product Label (Roslavointso)
* Please review the disclaimer below.
